Join Now

Yearly Archives: 2020

BioUtah’s Newest Associate Member: Greg Gunn, Colliers International

BioUtah’s newest Associate Member is Greg Gunn at Colliers International.  With over 35 years of experience in commercial real estate, Greg has negotiated over $700 million in leases representing properties anywhere from 1,000 to 145,000 square feet in size.  As a Senior Vice President at Colliers International, Greg has been impressed with the growth of […]

Posted in BioUtah News, Featured Members | Leave a comment

AdvaMed Request for Tariff Exclusions for Medical Technology Products

The Advanced Medical Technology Association (AdvaMed) has consistently indicated that the United States should not be imposing tariffs on medical technology. USTR’s moves in that direction are welcome. We are grateful to USTR for its recent decision to grant exclusions for a range of personal protective equipment (PPE) imports from China. This action could help […]

Posted in COVID-19 Updates, Utah's Life Sciences Companies | Leave a comment

State Legislature Wraps Up Special Sessions

Last week, the Utah State Legislature wrapped up three special sessions in which lawmakers passed a number of bills to respond to the COVID-19 crisis, including measures to expand unemployment benefits and to provide immunity from coronavirus claims for business operators. Another special session will be held, likely in May, to consider adjustments to the […]

Posted in COVID-19 Updates, State News | Leave a comment

PhotoPharmics Gets FDA Breakthrough Status for Parkinson’s PhotoTherapy

PhotoPharmics, a pioneer in specialized phototherapy, announced on April 29, that it has received FDA Breakthrough device designation for the company’s non-invasive Specialized Phototherapy Device. “Hats off to Utah’s PhotoPharmics,” said Kelvyn Cullimore, president and CEO of BioUtah. “Earning this Breakthrough designation is a significant value driver for a privately-owned device company.” “Our device is […]

Posted in Life Sciences Industry News | Leave a comment

Sodium Chloride(NaCI)Aerosol Test Final Report

Summary: This procedure was performed to evaluate the particle penetration and air flow resistance properties of filtration materials. A neutralized, poly-dispersed aerosol of sodium chloride(NaCI) was generated and passed through the test article. The performance of the test article was assessed by measuring the concentration of salt particles penetrating the test article compared to the […]

Posted in Policy News | Leave a comment

KidneyIntelX™ to predict major adverse kidney events in COVID-19 patients

Renalytix AI plc (LSE: RENX), the AIM-traded developer of clinical grade artificial intelligence in vitro diagnostics for kidney disease, announces that the KidneyIntelX™ platform will be used by investigators from the Icahn School of Medicine at Mount Sinai to assess the risk of adverse kidney events in patients diagnosed with COVID-19. Acute and chronic kidney disease is strongly associated with severity […]

Posted in COVID-19 Updates | Leave a comment

FDA Grants Breakthrough Designation for Non-Invasive Phototherapy Device in Parkinson’s Disease

PhotoPharmics achieves priority designation for innovative PD therapy April 29, 2020, Salt Lake City, UT— PhotoPharmics, a pioneer in specialized phototherapy, today announced that it has received FDA Breakthrough device designation for the company’s non-invasive Specialized Phototherapy Device. This prescription device is intended as an adjunct therapy for the treatment of Parkinson’s disease. It is […]

Posted in Life Sciences Industry News | Leave a comment

Lunch and Learn: What to Know About 409A Valuations

Gregg Hamilton-Piercy, The MFA Companies & Kurt Sheline, Echo Health Ventures, will discuss some of the most common valuation methods. Join Gregg Hamilton-Piercy, CFA, ASA, The MFA Companies, and Kurt Sheline, Echo Health Ventures, for a Lunch and Learn discussion on some of the most common valuation methods being used, the typical investment terms to expect from […]

Posted in Life Sciences Events | Leave a comment

Lunch & Learn: The Payer Perspective

Join Cambia Grove for The Payer Perspective with Nic Anderson, Managing Partner at LDD Partners, and Jeremy Porter, Operating Partner at Waveny Ventures, to discuss incorporating health economics and a market access strategy into your business plan. This Lunch & Learn will be taking place virtually.  Learn more and register here.

Posted in Life Sciences Events | Leave a comment

Congress Approves New $484 Billion COVID-19 Relief Bill, More Funding for PPP

A fourth “interim” bipartisan relief package, the Paycheck Protection Program and Health Care Enhancement Act (H.R. 266), totaling $484 billion, is on its way to the President’s desk for signature. Yesterday, the House easily passed the measure, which would put over $300 billion into the depleted Paycheck Protection Program (PPP), support hospitals, and expand testing […]

Posted in COVID-19 Updates, Federal News | Leave a comment

Merit Medical Systems Designs and Produces Sample Collection and Transport Kit

Press release courtesy of globenewswire.com April 20, 2020 09:25 ET | Source: Merit Medical Systems, Inc. SOUTH JORDAN, Utah, April 20, 2020 (GLOBE NEWSWIRE) — Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology, radiology and endoscopy, announced today that it has commenced production of a sample collection […]

Posted in COVID-19 Updates | Leave a comment

UTAH LAUNCHES HEALTHY TOGETHER APP TO ASSESS, TRACE SPREAD OF COVID-19

On April 22, Governor Herbert announced a new mobile platform that will provide COVID-19 symptom tracking, connects users with testing, and augment current contact tracing mechanisms. In releasing the app, the Governor said, “the more Utahns choose to use this application, the more clearly our public health teams will be able to see exactly where, […]

Posted in COVID-19 Updates, State News | Leave a comment